chr4-74748100-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001729.4(BTC):āc.478A>Gā(p.Thr160Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000205 in 1,610,746 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001729.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BTC | NM_001729.4 | c.478A>G | p.Thr160Ala | missense_variant | 5/6 | ENST00000395743.8 | |
BTC | NM_001316963.2 | c.331A>G | p.Thr111Ala | missense_variant | 4/5 | ||
BTC | XM_011532211.2 | c.478A>G | p.Thr160Ala | missense_variant | 5/6 | ||
BTC | XM_047416103.1 | c.331A>G | p.Thr111Ala | missense_variant | 4/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BTC | ENST00000395743.8 | c.478A>G | p.Thr160Ala | missense_variant | 5/6 | 1 | NM_001729.4 | P1 | |
BTC | ENST00000512743.1 | c.268A>G | p.Thr90Ala | missense_variant | 3/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000441 AC: 11AN: 249710Hom.: 0 AF XY: 0.0000518 AC XY: 7AN XY: 135100
GnomAD4 exome AF: 0.0000206 AC: 30AN: 1458592Hom.: 0 Cov.: 29 AF XY: 0.0000234 AC XY: 17AN XY: 725802
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 27, 2022 | The c.478A>G (p.T160A) alteration is located in exon 5 (coding exon 5) of the BTC gene. This alteration results from a A to G substitution at nucleotide position 478, causing the threonine (T) at amino acid position 160 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at